SIRT6 and non-small cell lung carcinoma: The antiproliferative effect of MDL-800 was significantly diminished by the SIRT6 knockdown was significantly attenuated, suggesting that MDL-800 is an effective activator to inhibit the proliferation of NSCLC 246.